Business Context and Reporting Period
This Form 8-K is filed by Sonim Technologies, Inc. (not DNA X, Inc.) on April 28, 2021. The company is incorporated in Delaware and its common stock (Symbol: SONM) trades on the Nasdaq Capital Market. The filing addresses a regulatory notice regarding the company's continued listing status.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the stock price performance triggering the regulatory notice: the closing bid price of the common stock was below $1.00 per share for the last 30 consecutive business days.
Material Changes
- Listing Deficiency: The company received a deficiency letter from Nasdaq for failing to meet the Minimum Bid Requirement (Rule 5450(a)(1)).
- Compliance Period: The company has been granted a 180-calendar-day compliance period to regain compliance, expiring on October 25, 2021.
- Remediation Requirement: To regain compliance, the stock must close at or above $1.00 per share for a minimum of 10 consecutive trading days within the compliance period.
Outlook, Risks, and Management Commentary
Management intends to actively monitor the stock price and is evaluating options to regain compliance, including the potential effecting of a reverse stock split. The filing explicitly states there can be no assurance that the company will regain compliance or remain listed on Nasdaq. If the company fails to cure the deficiency within the initial 180 days, it may be eligible for an additional 180-day period if it meets other listing standards (such as market value of publicly held shares). Failure to cure could result in delisting, though the company retains the right to appeal such a determination to a Hearings Panel.
Investor Verification Checklist
- Verify the current closing bid price of SONM stock to assess proximity to the $1.00 threshold.
- Monitor for announcements regarding a potential reverse stock split.
- Check for any subsequent correspondence from Nasdaq regarding the extension of the compliance period or delisting notices.
- Review the company's market value of publicly held shares to determine eligibility for a second compliance period if the first is missed.